Sen. Claire McCaskill (D-Mo.) said that Teva Pharmaceuticals (NYSE:TEVA) is “stonewalling” a Senate probe into the the role that opioid manufacturers have in the nation’s opioid crisis.
In the senator’s initial inquiries with the generic drugmaker, McCaskill requested an array of documents detailing arrangements between Teva and its customers, as well as internal reviews of pharmacies and other buyers.
Get the full story at our sister site, Drug Delivery Business News.
The post Sen. McCaskill: Teva is “stonewalling” Senate investigation into opioid crisis appeared first on MassDevice.